Sr# |
Name of material |
Cas# |
Structure |
1 |
Fmoc-Cys(trt)-OH |
103213-32-7 |
![Peptide manufacturing companies in India](img/peptide/peptide-building-blocks_clip_image002.jpg) |
2 |
Fmoc-D-Cys(trt)-OH |
167015-11-4 |
![Peptide manufacturing companies in India](img/peptide/peptide-building-blocks_clip_image004.jpg) |
3 |
Fmoc-Thr(tbu)-OH |
71989-35-0 |
![Peptide manufacturing companies in India](img/peptide/peptide-building-blocks_clip_image006.jpg) |
4 |
Fmoc-D-Thr(tbu)-OH |
138797-71-4 |
![](img/peptide/peptide-building-blocks_clip_image008.jpg) |
5 |
Fmoc-Lys(Boc)-OH |
71989-26-9 |
![](img/peptide/peptide-building-blocks_clip_image010.jpg) |
6 |
Fmoc-D-Lys(Boc)-OH |
92122-45-7 |
![](img/peptide/peptide-building-blocks_clip_image012.jpg) |
7 |
Fmoc-Trp(Boc)-OH |
143824-78-6 |
![](img/peptide/peptide-building-blocks_clip_image014.jpg) |
8 |
Fmoc-D-Trp(Boc)-OH |
163619-04-3 |
![](img/peptide/peptide-building-blocks_clip_image016.jpg) |
9 |
Fmoc-Phe-OH |
35661-40-6 |
![](img/peptide/peptide-building-blocks_clip_image018.jpg) |
10 |
Fmoc-D-Phe-OH |
86123-10-6 |
![](img/peptide/peptide-building-blocks_clip_image020.jpg) |
11 |
Fmoc-Thr(tbu)-OL |
189337-28-8 |
<![](img/peptide/peptide-building-blocks_clip_image022.png) |
12 |
Fmoc-Ala-OH |
35661-39-3 |
![](img/peptide/peptide-building-blocks_clip_image024.jpg) |
13 |
Fmoc-D-Ala-OH |
79990-15-1 |
![](img/peptide/peptide-building-blocks_clip_image026.jpg) |
14 |
Fmoc-Pro-OH |
71989-31-6 |
![](img/peptide/peptide-building-blocks_clip_image028.jpg) |
15 |
Fmoc-D-Pro-OH |
101555-62-8 |
![](img/peptide/peptide-building-blocks_clip_image030.jpg) |
16 |
Fmoc-Leu-OH |
35661-60-0 |
![#](img/peptide/peptide-building-blocks_clip_image032.jpg) |
17 |
Fmoc-D-Leu-OH |
114360-54-2 |
![](img/peptide/peptide-building-blocks_clip_image034.jpg) |
18 |
Fmoc-Ser(tBu)-OH |
71989-33-8 |
![](img/peptide/peptide-building-blocks_clip_image036.jpg) |
19 |
Fmoc-D-Ser(tBu)-OH |
128107-47-1 |
![](img/peptide/peptide-building-blocks_clip_image038.jpg) |
20 |
Fmoc-L-Phe(4-Cl)-OH |
175453-08-4 |
![Structure](img/peptide/peptide-building-blocks_clip_image040.jpg) |
21 |
Fmoc-D-Phe(4-Cl)-OH |
142994-19-2 |
![Fmoc-D-Phe(4-Cl)-OH](img/peptide/peptide-building-blocks_clip_image042.jpg) |
22 |
Fmoc-2-Nal-OH |
112883-43-9 |
![Fmoc-2-Nal-OH ≥98.0% (HPLC)](img/peptide/peptide-building-blocks_clip_image044.jpg) |
23 |
Fmoc-D-2-Nal-OH |
138774-94-4 |
![Fmoc-D-2-Nal-OH ≥98.0% (HPLC)](img/peptide/peptide-building-blocks_clip_image046.jpg) |
24 |
Fmoc-L-3-PAL-OH |
175453-07-3 |
![Fmoc-β-(3-pyridyl)-Ala-OH ≥98.0%](img/peptide/peptide-building-blocks_clip_image048.jpg) |
25 |
Fmoc-D-3-PAL-OH |
142994-45-4 |
![Fmoc-β-(3-pyridyl)-D-Ala-OH purum, ≥98.0% (HPLC)](img/peptide/peptide-building-blocks_clip_image050.jpg) |
26 |
Boc-Phe-OH |
13734-34-4 |
![Boc-Phe-OH ≥99.0% (T)](img/peptide/peptide-building-blocks_clip_image052.jpg) |
27 |
Boc-D-Phe-OH |
18942-49-9 |
![Boc-D-Phe-OH ≥99.0% (sum of enantiomers, TLC)](img/peptide/peptide-building-blocks_clip_image054.jpg) |
28 |
Fmoc-Arg(Pbf)-OH |
154445-77-9 |
![Fmoc-Arg(Pbf)-OH ≥98.0% (HPLC)](img/peptide/peptide-building-blocks_clip_image056.jpg) |
29 |
Fmoc-D-Arg(Pbf)-OH |
187618-60-6 |
![Fmoc-D-Arg(Pbf)-OH ≥98.0% (TLC)](img/peptide/peptide-building-blocks_clip_image058.jpg) |
30 |
Fmoc-His(Boc)-OH |
81379-52-4 |
![](img/peptide/peptide-building-blocks_clip_image060.jpg) |
31 |
Boc-His-OH |
17791-52-5 |
![Boc-His-OH 99%](img/peptide/peptide-building-blocks_clip_image062.jpg) |
32 |
Boc-D-His-OH |
50654-94-9 |
![Boc-D-His-OH ≥98.0% (TLC)](img/peptide/peptide-building-blocks_clip_image064.jpg) |
33 |
Fmoc-His(Boc)-OH.CHA |
210820-99-8 |
![Fmoc-His(Boc)-OH-CHA Novabiochem®](img/peptide/peptide-building-blocks_clip_image066.jpg) |
34 |
Fmoc-Tyr(Me)-OH |
77128-72-4 |
![Fmoc-His(Boc)-OH-CHA Novabiochem®](img/peptide/Fmoc-TyrMe-OH[852056-Fmoc-TyrMe-OH-ALL].jpg) |
35 |
Fmoc-Tyr(tBu)-OH |
71989-38-3 |
![Fmoc-Tyr(tBu)-OH ≥98.0% (HPLC)](img/peptide/peptide-building-blocks_clip_image068.jpg) |
36 |
Fmoc-D-Tyr(tBu)-OH |
118488-18-9 |
![Fmoc-D-Tyr(tBu)-OH ≥98.0% (HPLC)](img/peptide/peptide-building-blocks_clip_image070.jpg) |
37 |
H-Pro-NHEt hydrochloride |
58107-62-3 |
![H-Pro-NHEt hydrochloride AldrichCPR](img/peptide/peptide-building-blocks_clip_image072.jpg) |
38 |
H-D-Pro-NHEt hydrochloride |
1225063-04-6 |
![Chemical Structure| 1225063-04-6](img/peptide/peptide-building-blocks_clip_image074.png) |
39 |
Boc-Arg(pbf)-OH |
200124-22-7 |
![Boc-Arg(Pbf)-OH ≥98.0% (TLC)](img/peptide/peptide-building-blocks_clip_image076.jpg) |
40 |
Boc-D-Arg(pbf)-OH |
186698-61-3 |
![](img/peptide/peptide-building-blocks_clip_image078.jpg) |
41 |
Fmoc-D-CIT-OH |
200344-33-8 |
![Fmoc-D-Cit-OH [200344-33-8]](img/peptide/peptide-building-blocks_clip_image080.jpg) |
42 |
Fmoc-Cit-OH |
133174-15-9 |
![Fmoc-Cit-OH ≥97.0% (HPLC)](img/peptide/peptide-building-blocks_clip_image082.jpg) |
43 |
Fmoc-Gln(Trt)-OH |
132327-80-1 |
![Fmoc-Gln(Trt)-OH ≥98.0% (HPLC)](img/peptide/peptide-building-blocks_clip_image084.jpg) |
44 |
Fmoc-D-Gln(Trt)-OH |
200623-62-7 |
![Fmoc-D-Gln(Trt)-OH 97%](img/peptide/peptide-building-blocks_clip_image086.jpg) |
45 |
Fmoc-Asn(Trt)-OH |
132388-59-1 |
![Fmoc-Asn(Trt)-OH ≥97.0%](img/peptide/peptide-building-blocks_clip_image088.jpg) |
46 |
N-Boc-L-tert-Leucine |
62965-35-9 |
![Boc-Tle-OH ≥99.0% (T)](img/peptide/peptide-building-blocks_clip_image090.png) |
47 |
Fmoc-Cys(Acm)-OH> |
86060-81-3 |
![Fmoc-Cys(Acm)-OH ≥95.0% (sum of enantiomers, HPLC)](img/peptide/peptide-building-blocks_clip_image092.jpg) |
48 |
Fmoc-D-Cys(Acm)-OH |
168300-88-7 |
![](img/peptide/peptide-building-blocks_clip_image094.jpg) |
49 |
Fmoc-Lys(Dde)-OH |
150629-67-7 |
![Fmoc-Lys(Dde)-OH Novabiochem®](img/peptide/peptide-building-blocks_clip_image096.jpg) |
50 |
Fmoc-D-Lys(Dde)-OH |
333973-51-6 |
![Fmoc-D-Lys(Dde)-OH Novabiochem®](img/peptide/peptide-building-blocks_clip_image098.jpg) |
51 |
H-Cys(Trt)-OH |
2799-07-7 |
![H-Cys(Trt)-OH [2799-07-7]](img/peptide/peptide-building-blocks_clip_image100.jpg) |
52 |
Fmoc-β-Ala-OH |
35737-10-1 |
![Fmoc-β-Ala-OH ≥99.0% (HPLC)](img/peptide/peptide-building-blocks_clip_image102.jpg) |
53 |
H-Cys(Acm)-OH. H2O |
19647-70-2 |
![H-Cys(Acm)-OH H2O [19647-70-2]](img/peptide/peptide-building-blocks_clip_image104.jpg) |
54 |
Z-Gln-OH |
2650-64-8 |
![Z-Gln-OH 99%](img/peptide/peptide-building-blocks_clip_image106.jpg) |
55 |
Fmoc-Ile-OH |
71989-23-6 |
![Fmoc-Ile-OH ≥98.0% (T)](img/peptide/peptide-building-blocks_clip_image108.jpg) |
56 |
Fmoc-D-Ile-OH |
143688-83-9 |
![Fmoc-D-Ile-OH ≥96.0% (HPLC)](img/peptide/peptide-building-blocks_clip_image110.jpg) |
57 |
Fmoc-L-His(Trt)-OH |
109425-51-6 |
![Fmoc-His(Trt)-OH ≥98.0% (sum of enantiomers, HPLC)](img/peptide/peptide-building-blocks_clip_image112.jpg) |
58 |
Fmoc-D-His(Trt)-OH |
135610-90-1 |
![Fmoc-D-His(Trt)-OH Novabiochem®](img/peptide/peptide-building-blocks_clip_image114.jpg) |
59 |
Fmoc-Val-OH |
68858-20-8 |
![Fmoc-Val-OH ≥98.0% (HPLC)](img/peptide/peptide-building-blocks_clip_image116.jpg) |
60 |
Fmoc-D-Val-OH |
84624-17-9 |
![Fmoc-D-Val-OH ≥98.0% (HPLC)](img/peptide/peptide-building-blocks_clip_image118.jpg) |
61 |
Fmoc-Asp (OtBu)-OH |
71989-14-5 |
![Fmoc-Asp(OtBu)-OH ≥98.0% (HPLC)](img/peptide/peptide-building-blocks_clip_image120.jpg) |
62 |
Fmoc-D-Asp (OtBu)-OH |
112883-39-3 |
![Fmoc-D-Asp(OtBu)-OH 98%](img/peptide/peptide-building-blocks_clip_image122.jpg) |
63 |
Fmoc-Lys(Alloc)-OH |
146982-27-6 |
![Fmoc-Lys(Alloc)-OH ≥95.0% (HPLC)](img/peptide/peptide-building-blocks_clip_image124.jpg) |
64 |
Fmoc-D-Lys(Alloc)-OH |
214750-75-1 |
![Fmoc-D-Lys(Alloc)-OH ≥98.0% (HPLC)](img/peptide/peptide-building-blocks_clip_image126.jpg) |
65 |
Fmoc-Glu(OtBu)-OH |
71989-18-9 |
![Fmoc-Glu(OtBu)-OH ≥98.0% (HPLC)](img/peptide/peptide-building-blocks_clip_image128.jpg) |
66 |
Fmoc-D-Glu(OtBu)-OH |
104091-08-9 |
![Fmoc-D-Glu(OtBu)-OH ≥98.0% (HPLC)](img/peptide/peptide-building-blocks_clip_image130.jpg) |
67 |
Fmoc-Gly-OH |
29022-11-5 |
![Fmoc-Gly-OH ≥98.0% (T)](img/peptide/peptide-building-blocks_clip_image132.jpg) |
68 |
Fmoc-Aib-OH |
94744-50-0 |
![Fmoc-Aib-OH Novabiochem®](img/peptide/peptide-building-blocks_clip_image134.jpg) |
69 |
Fmoc-AEEA-OH |
166108-71-0 |
![Fmoc-AEEA [166108-71-0]](img/peptide/peptide-building-blocks_clip_image135.png) |
70 |
Fmoc-Orn(Boc)-OH |
109425-55-0 |
![Fmoc-Orn(Boc)-OH ≥96.0% (HPLC)](img/peptide/peptide-building-blocks_clip_image137.jpg) |
71 |
Fmoc-D-Tyr(4-Et)-OH |
162502-65-0 |
![See the source image](img/peptide/peptide-building-blocks_clip_image139.jpg) |
72 |
FMOC-L-LYS[C20-OTBU-GLU(OTBU)-AEEA-AEEA]-OH |
2460751-66-8 |
![2460751-66-8 structure](img/peptide/peptide-building-blocks_clip_image141.jpg)
|
73 |
Fmoc-Met-OH |
71989-28-1 |
![Fmoc-Met-OH ≥98.0% (HPLC)](img/peptide/peptide-building-blocks_clip_image143.jpg) |
74 |
Fmoc-Ser-OH |
73724-45-5 |
![Fmoc-Ser-OH ≥97.0% (sum of enantiomers, HPLC)](img/peptide/peptide-building-blocks_clip_image145.png) |
75 |
Fmoc-D-Ser-OH |
116861-26-8 |
![Fmoc-D-Ser-OH ≥98.0%](img/peptide/peptide-building-blocks_clip_image147.jpg) |
76 |
Fmoc-Asn-OH |
71989-16-7 |
![Fmoc-Asn-OH Novabiochem®](img/peptide/peptide-building-blocks_clip_image149.jpg) |
77 |
Fmoc-D-Asn-OH |
108321-39-7 |
![Fmoc-D-Asn-OH Novabiochem®](img/peptide/peptide-building-blocks_clip_image151.jpg) |
78 |
Fmoc-Gln-OH |
71989-20-3 |
![Fmoc-Gln-OH Novabiochem®](img/peptide/peptide-building-blocks_clip_image153.jpg) |
79 |
Fmoc-D-Gln-OH |
112898-00-7 |
![Fmoc-D-Gln-OH ≥98.0%](img/peptide/peptide-building-blocks_clip_image155.jpg) |
80 |
FMOC-L-LYS[OCT-(OTBU)-GLU-(OTBU)-AEEA-AEEA]OH |
1662688-20-1 |
![See the source image](img/peptide/peptide-building-blocks_clip_image157.png) |
81 |
tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu |
1118767-16-0 |
![tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu Structure](img/peptide/peptide-building-blocks_clip_image159.png) |
82 |
Fmoc-8-amino-3,6-dioxaoctanoic acid |
166108-71-0 |
![Image result for 166108-71-0](img/peptide/peptide-building-blocks_clip_image161.jpg) |
83 |
2,2-Dimethyl-4-oxo-3,8,11-trioxa-5-azatridecan-13-oic acid |
108466-89-3 |
![See the source image](img/peptide/peptide-building-blocks_clip_image163.jpg) |
84 |
Fmoc-Thr-Ol |
176380-53-3 |
![](img/peptide/peptide-building-blocks_clip_image164.jpg) |
85 |
Fmoc-Cys(Mmt)-OH |
177582-21-7 |
![Fmoc-Cys(Mmt)-OH Novabiochem®](img/peptide/peptide-building-blocks_clip_image166.jpg) |
86 |
Fmoc-D-Cys(Mmt)-OH |
1198791-73-9 |
![Fmoc-D-Cys(Mmt)-OH Structure](img/peptide/peptide-building-blocks_clip_image168.jpg) |
87 |
N-benzyl-L-proline |
31795-93-4 |
![See the source image](img/peptide/peptide-building-blocks_clip_image170.png) |
88 |
N-benzyl-D-proline |
56080-99-0 |
![CAS # 56080-99-0, N-Benzyl-D-proline](img/peptide/peptide-building-blocks_clip_image171.png) |
88 |
Boc-L-proline |
15761-39-4 |
![Boc-Pro-OH 99%](img/peptide/peptide-building-blocks_clip_image173.jpg) |
89 |
Boc-D-proline |
37784-17-1 |
![Boc-D-Pro-OH](img/peptide/peptide-building-blocks_clip_image175.jpg) |